 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
China bans antibiotic following three deaths
Beijing, Aug 6, 2006 China has banned an antibiotic suspected of killing three, including a little girl, and sickening 78 others, state media said Sunday. The State Food and Drug Administration has ordered an end to the use of clindamycin phosphate glucose and started a nationwide recall before it hurts more people, the Xinhua news agency reported. The drug, used to treat bacterial infections, is produced by Anhui Huayuan Worldbest Biology Pharmacy Co. in east China's Anhui province, according to the agency. A six-year-old girl in the northeastern city of Harbin died on July 27 after she was injected with the drug while being treated for a common cold, Xinhua said. The drug is also suspected of having caused the death Wednesday of a 48-year-old woman in the central province of Hubei, the agency said. It did not give details about the third reported fatality. Symptoms among patients sickened by the drug include kidney pains, stomach aches, nausea, vomiting and chest pains, Xinhua said. China's poorly regulated pharmaceutical industry has frequently been in the spotlight for making products that did more harm than good to their users. The government banned a gel used for breast enlargements in May after hundreds of women injected with the fluid reported suffering severe pain and other health problems. Earlier this year, several Chinese patients also died after taking a counterfeit drug ostensibly meant to treat gallstones and gastritis. Community Email This Article Comment On This Article Related Links China News from SinoDaily.com
Russia and China indicate support for Mideast resolution
United Nations, Aug 5, 2006 Russia and China said Saturday that the new UN resolution on the Middle East war drawn up by France and the United States would have to be accepted by Israel and Lebanon to achieve any success. |
|
|
| The content herein, unless otherwise known to be public domain, are Copyright 1995-2006 - SpaceDaily.AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA PortalReports are copyright European Space Agency. All NASA sourced material is public domain. Additionalcopyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement |
